logo
Select company
Select metric
3Enterprise Value over EBIT
VS
Market
99
Sector
98
Industry
96
History
-
$ 5.53Close
$ 4.18 - $ 7.23 52-Week Range
Ticker Information

Ticker

ABEO

Company Name

ABEONA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABEONA THERAPEUTICS INC - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABEO - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ 76.89M$ 230.95M3
3/31/2025$ -39.93M$ 303.9M0
12/31/2024$ -59.53M$ 248.82M0
9/30/2024$ -67.8M$ 265.7M0
6/30/2024$ -50.36M$ 202.81M0
3/31/2024$ -75.39M$ 199.26M0
12/31/2023$ -53.77M$ 181.8M0
9/30/2023$ -38.24M$ 112.12M0
6/30/2023$ -35.83M$ 73.18M0
3/31/2023$ -27.26M$ 58.07M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for ABEONA THERAPEUTICS INC is calculated as follows: EV [ $ 105.98M ] / EBIT [ $ -81.71M ]
(=) EV/EBIT [ 0 ]

ABEO - Enterprise Value over EBIT, Last 5 years

3

Minimum

Jun 30, 2025

3

Maximum

Jun 30, 2025

3

Average

3

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.8
std12.32